RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
This Quarter Return
+1.05%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$6.63B
AUM Growth
+$6.63B
(-7.3%)
Cap. Flow
-$82.7M
Cap. Flow
% of AUM
-1.25%
Top 10 Holdings %
Top 10 Hldgs %
50.25%
Holding
100
New
18
Increased
9
Reduced
13
Closed
18
Top Buys
| 1 |
Vor Biopharma
VOR
|
$479M |
| 2 |
Instil Bio
TIL
|
$122M |
| 3 |
Edgewise Therapeutics
EWTX
|
$84.9M |
| 4 |
Bolt Biotherapeutics
BOLT
|
$78.3M |
| 5 |
Seres Therapeutics
MCRB
|
$76.1M |
Top Sells
| 1 |
Arvinas
ARVN
|
$312M |
| 2 |
TG Therapeutics
TGTX
|
$195M |
| 3 |
Novavax
NVAX
|
$143M |
| 4 |
Keros Therapeutics
KROS
|
$132M |
| 5 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$72.9M |
Sector Composition
| 1 | Healthcare | 95.53% |
| 2 | Financials | 0.47% |
